C30-C39
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Phase 3 (outcome evaluation) Randomized controlled trial with patients: -Patients: requirements for milestone-consultations fulfilled (newly diagnosed incurable lung cancer (stage IV)), 18 years and older, capability to give consent, good knowledge of German language, willingness to participate in study -Relatives of patients: 18 years and older, capability to give consent, good knowledge of German language, willingness to participate in study
Exclusion criteria
Exclusion criteria: -Patient does not speak German -Patient is in a medical condition (e.g. acute life-threatening condition), which does not allow consultations
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes: Supportive care needs: SCNS-SF34-G (for patients), SCNS-SF34-P&C-G (for relatives), in the HeiMeKOM-group: IPOS (Integrated Palliative Care Outcome Scale) Quality of Life: SEIQoL-Q, FACT-G, FACT-L, PHQ-4 Patient Distress: Distress-Thermometer | — |
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study are the effects on the dimension “Health system/ Information” of the Short Form of the Supportive Care Needs Survey (SCNS-SF-34). | — |
Countries
Germany
Contacts
Thoraxklinik Heidelberg gGmbH